We provide you with 20 years of free, institutional-grade data for CRBU stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CRBU. Explore the full financial landscape of CRBU stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Haurwitz Rachel E. | Grant, award...etc | 665,650 | 2024-02-22 | ||
| Kanner Steven | Grant, award...etc | 186,000 | 2024-02-22 | ||
| Zheng Ran | Grant, award...etc | 39,500 | 2024-02-22 | ||
| Whiting Nancy | Grant, award...etc | 39,500 | 2024-02-22 | ||
| Sacks Natalie | Grant, award...etc | 39,500 | 2024-02-22 | ||
| Richardson-Heron Dara | Grant, award...etc | 39,500 | 2024-02-22 | ||
| JOHNSON DAVID LEE | Grant, award...etc | 39,500 | 2024-02-22 | ||
| GUGGENHIME ANDREW | Grant, award...etc | 39,500 | 2024-02-22 | ||
| Braunstein Scott | Grant, award...etc | 39,500 | 2024-02-22 | ||
| Khan Ruhi Ahmad | Grant, award...etc | 186,000 | 2024-02-22 | ||
| MCCLUNG BARBARA G | Grant, award...etc | 186,000 | 2024-02-22 | ||
| O'Byrne Jason | Grant, award...etc | 186,000 | 2024-02-22 | ||
| Kanner Steven | Derivatives Exercise | 0 | 2024-02-08 | ||
| Kelly Timothy P | Grant, award...etc | 300,000 | 2024-01-09 | ||
| Haurwitz Rachel E. | Derivatives Exercise | 0 | 2023-06-09 | ||
| Haurwitz Rachel E. | Derivatives Exercise | 0 | 2023-03-22 | ||
| Richardson-Heron Dara | Grant, award...etc | 21,500 | 2023-02-23 | ||
| Khan Ruhi Ahmad | Grant, award...etc | 131,000 | 2023-02-23 | ||
| Sacks Natalie | Grant, award...etc | 21,500 | 2023-02-23 | ||
| Braunstein Scott | Grant, award...etc | 21,500 | 2023-02-23 | ||
| GUGGENHIME ANDREW | Grant, award...etc | 21,500 | 2023-02-23 | ||
| MCCLUNG BARBARA G | Grant, award...etc | 131,000 | 2023-02-23 | ||
| Rizvi Syed Ali-aamir | Grant, award...etc | 131,000 | 2023-02-23 | ||
| Zheng Ran | Grant, award...etc | 21,500 | 2023-02-23 | ||
| Whiting Nancy | Grant, award...etc | 21,500 | 2023-02-23 | ||
| O'Byrne Jason | Grant, award...etc | 131,000 | 2023-02-23 | ||
| JOHNSON DAVID LEE | Grant, award...etc | 21,500 | 2023-02-23 | ||
| Kanner Steven | Grant, award...etc | 131,000 | 2023-02-23 | ||
| Haurwitz Rachel E. | Grant, award...etc | 510,500 | 2023-02-23 | ||
| Rizvi Syed Ali-aamir | Sale | -5,627 | $6.31 | $35,506 | 2023-01-20 |
| Kanner Steven | Derivatives Exercise | 0 | 2022-12-02 | ||
| Fischesser Ryan | Sale | -10,000 | $10.8 | $107,958 | 2022-10-07 |
| Fischesser Ryan | Derivatives Exercise | 0 | 2022-10-07 | ||
| MCCLUNG BARBARA G | Derivatives Exercise | 0 | 2022-09-16 | ||
| Kanner Steven | Sale | -43,248 | $11.22 | $485,221 | 2022-08-26 |
| Kanner Steven | Derivatives Exercise | 0 | 2022-08-26 | ||
| Khan Ruhi Ahmad | Grant, award...etc | 70,000 | 2022-08-24 | ||
| Fischesser Ryan | Grant, award...etc | 4,848 | 2022-08-24 | ||
| JOHNSON DAVID LEE | Grant, award...etc | 44,000 | 2022-05-18 | ||
| Kanner Steven | Derivatives Exercise | 0 | 2022-05-17 | ||
| Haurwitz Rachel E. | Derivatives Exercise | 0 | 2022-05-10 | ||
| Fischesser Ryan | Derivatives Exercise | 0 | 2022-05-06 | ||
| Fischesser Ryan | Derivatives Exercise | 0 | 2022-03-17 | ||
| Kanner Steven | Derivatives Exercise | 0 | 2022-03-07 | ||
| O'Byrne Jason | Derivatives Exercise | 0 | 2022-02-08 | ||
| Haurwitz Rachel E. | Derivatives Exercise | 0 | 2022-01-27 | ||
| Rizvi Syed Ali-aamir | Grant, award...etc | 221,250 | 2022-01-25 | ||
| Rizvi Syed Ali-aamir | Initial | 2022-01-24 | |||
| Fischesser Ryan | Open Market Purchase | 7,387 | $2.69 | 2022-01-12 | |
| Whiting Nancy | Grant, award...etc | 13,060 | 2021-12-22 | ||
| MCCLUNG BARBARA G | Grant, award...etc | 147,000 | 2021-12-21 | ||
| Kanner Steven | Grant, award...etc | 147,000 | 2021-12-21 | ||
| Haurwitz Rachel E. | Grant, award...etc | 411,000 | 2021-12-21 | ||
| Fischesser Ryan | Open Market Purchase | 1,136 | $2.69 | 2021-12-21 | |
| Fischesser Ryan | Grant, award...etc | 40,000 | 2021-12-21 | ||
| GUGGENHIME ANDREW | Grant, award...etc | 27,500 | 2021-12-21 | ||
| Braunstein Scott | Grant, award...etc | 27,500 | 2021-12-21 | ||
| Zheng Ran | Grant, award...etc | 13,750 | 2021-12-21 | ||
| Sacks Natalie | Grant, award...etc | 27,500 | 2021-12-21 | ||
| Whiting Nancy | Grant, award...etc | 13,750 | 2021-12-21 | ||
| O'Byrne Jason | Grant, award...etc | 147,000 | 2021-12-21 | ||
| MCCLUNG BARBARA G | Open Market Purchase | 6,127 | $2.69 | 2021-12-08 | |
| Khan Ruhi Ahmad | Grant, award...etc | 225,000 | 2021-11-16 | ||
| Richardson-Heron Dara | Grant, award...etc | 44,000 | 2021-11-15 | ||
| MCCLUNG BARBARA G | Open Market Purchase | 9,219 | $2.69 | 2021-10-21 | |
| Kanner Steven | Open Market Purchase | 114,860 | $1.81 | 2021-10-13 | |
| Fischesser Ryan | Open Market Purchase | 1,746 | $2.69 | 2021-10-12 | |
| Fischesser Ryan | Initial | 2021-07-23 | |||
| Haurwitz Rachel E. | Initial | 2021-07-22 | |||
| Kanner Steven | Initial | 2021-07-22 | |||
| MCCLUNG BARBARA G | Initial | 2021-07-22 |
The information provided in this report about CRBU stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Caribou Biosciences Inc(NASDAQ:CRBU) 
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Website: https://www.cariboubio.com/
Founded: 2011
CEO / Co-Founder: Rachel Haurwitz
Sector:
Industry:
Share this website to your friends